CRISPR RNPs Advancing Gene & Cell Therapy
EXPLORE THE ALDEVRON ADVANTAGE
*Aldevron provides RNPs only to customers who are duly licensed, including to make and have made RNPs, for their intended use.
Learn more about CRISPR RNPs and the Future of Cell and Gene Therapy by Thomas Lynch, Ph.D., VP Client Services.
Schedule a 1:1 consultation with Allison Pappas, Ph.D. on how our RNP service can help meet your research and clinical goals.
Senior Manager, Client Relations - Gene Editing, Aldevron
Allison Pappas leads Aldevron's Gene Editing Client Relations team and specializes in helping clients obtain high quality gene editing enzymes and RNPs, from Research grade through GMP. She has a strong understanding of GMP requirements, having worked in GMP QC release and stability of biopharmaceuticals before joining Aldevron. Her scientific expertise is in the evolution and characterization of RNA:protein complexes. Dr. Pappas holds a Ph.D. in genetics from Iowa State University and a B.S. in microbiology from Indiana University - Bloomington.